Try The Drug Club risk-free for 30 days Trial terms

Fosinopril — $0 on Listed Strengths

Fosinopril is $0 on listed strengths only. Other strengths are not a blanket $0.

Fosinopril Pricing

Pricing typePrice
TheDrugClub$0 on listed strengths
Typical Retail$151.00

$0 on listed strengths: 10mg Tablet (max 90); 20mg Tablet (max 90); 40mg Tablet (max 90)

About Fosinopril

Fosinopril is a prescription medication. Ask your doctor if Fosinopril is right for you.

Other strengths and forms of Fosinopril

How to Check Fosinopril Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

Fosinopril at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Other medications in Heart & Cardiovascular

What Fosinopril is approved for (FDA label)

Fosinopril sodium tablets are indicated for the treatment of hypertension. It may be used alone or in combination with thiazide diuretics. Fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see DOSAGE AND ADMINISTRATION ). In using fosinopril sodium, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that fosinopril sodium does not have a similar risk (see WARNINGS ).

Source: Read the full FDA label on DailyMed. Label effective date: November 27, 2023.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Fosinopril (FDA label)

WARNING: FETAL TOXICITY When pregnancy is detected, discontinue fosinopril sodium tablets as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. See WARNINGS: Fetal Toxicity

Source: FDA prescribing information (DailyMed). Set ID: fc38f1bb-f175-4a81-8ed9-c8701efdea35. SPL document ID: 45aabe20-10c6-4b99-989a-2b64bd266114. Label effective date: November 27, 2023. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Fosinopril (FDA label)

Fosinopril sodium has been evaluated for safety in more than 2100 individuals in hypertension and heart failure trials, including approximately 530 patients treated for a year or more. Generally adverse events were mild and transient, and their frequency was not prominently related to dose within the recommended daily dosage range. Hypertension In placebo-controlled clinical trials (688 fosinopril sodium -treated patients), the usual duration of therapy was two to three months. Discontinuations due to any clinical or laboratory adverse event were 4.1% and 1.1% in fosinopril sodium-treated and placebo-treated patients, respectively.

Source: FDA prescribing information (DailyMed). Set ID: fc38f1bb-f175-4a81-8ed9-c8701efdea35. SPL document ID: 45aabe20-10c6-4b99-989a-2b64bd266114. Label effective date: November 27, 2023. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Fosinopril (FDA label)

Fosinopril sodium tablets are contraindicated in patients who are hypersensitive to this product or to any other angiotensin converting enzyme inhibitor (e.g., a patient who has experienced angioedema with any other ACE inhibitor therapy). Do not co-administer fosinopril sodium tablets with aliskiren in patients with diabetes.

Source: FDA prescribing information (DailyMed). Set ID: fc38f1bb-f175-4a81-8ed9-c8701efdea35. SPL document ID: 45aabe20-10c6-4b99-989a-2b64bd266114. Label effective date: November 27, 2023. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Fosinopril (FDA label)

With diuretics: Patients on diuretics, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril sodium. The possibility of hypotensive effects with fosinopril sodium can be minimized by either discontinuing the diuretic or increasing salt intake prior to initiation of treatment with fosinopril sodium. If this is not possible, the starting dose should be reduced and the patient should be observed closely for several hours following an initial dose and until blood pressure has stabilized. (see DOSAGE AND ADMINISTRATION ). With potassium supplements and potassium-sparing diuretics: Fosinopril sodium can attenuate potassium loss caused by thiazide diuretics. Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia. Therefore, if concomitant use of such agents is indicated, they should be given with caution, and the patient's serum potassium should be monitored frequently.

Source: FDA prescribing information (DailyMed). Set ID: fc38f1bb-f175-4a81-8ed9-c8701efdea35. SPL document ID: 45aabe20-10c6-4b99-989a-2b64bd266114. Label effective date: November 27, 2023. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial